Pulished Date October, 2018
ID: 61
Share on
Share on

North America Veterinary Vaccines Market By Type (Livestock Vaccines And Companion Vaccines), By Technology (live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines And Conjugate Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 61
Pages: 134

The North America animal vaccines market is poised to reach USD 2.55 Billion by 2023 from USD 2.01 Billion in 2018, at a CAGR of 4.93% from 2018 to 2023. The major goals of veterinary vaccines are to improve the health companion animals, increase production of livestock in a cost-effective manner, and prevent zoonotic disease transmission from both domestic and wild animals. Veterinary vaccine market has shown significant growth in recent years which can be attributed to increasing husbandry practices and better management of farms. This marks the estimation of further growth in the market due to advancement in biotechnological research.

The North America veterinary vaccines market has undergone considerable progress during the past few years with the growing usage of continuous cell lines as a substrate and embracing of the fermenter technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics. But it should be kept in mind that USDA APHIS regulations must be stringently followed for approval and distribution of veterinary biologics across USA which is the major economy in this region.

Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans; increasing investments by leading players, various government agencies and animal associations; continuous innovations, increasing awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into development of new products. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.

The North America veterinary vaccines market has been categorized as livestock and companion vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada.

Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                           

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                      

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Type                                                                        

                                5.1.1 Livestock vaccines                                                






                                5.1.2 Companion vaccines                                                           



                5.2 Technology                                                                 

                                5.2.1 Live attenuated vaccines                                                  

                                5.2.2 Inactivated vaccines                                                            

                                5.2.3 Recombinant vaccines                                                       

                                5.2.4 Toxoid vaccines                                                     

                                5.2.5 Subunit vaccines                                                   

                                5.2.6 DNA vaccines                                                         

                                5.2.7 Conjugate vaccines                                                             

  1. Geographical Analysis

                6.1 Introduction                                                                               

                6.2 United States                                                                            

                6.3 Canada                                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bayer Healthcare AG                                                                              

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Bioniche Animal Health Canada                                                                         

                8.3 Sanofi Animal Health Inc.                                                                      

                8.4 Biogenesis Bago SA                                                                 

                8.5 Heska Corporation                                                                  

                8.6 Indian Immunologicals Ltd.                                                                  

                8.7 Boehringer Ingelheim GmbH                                                                              

                8.8 Novartis Animal Health, Inc.                                                                

                8.9 Merck & Co. Inc.                                                                       

                8.10 Protein Sciences                                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Veterinary Vaccines Market By Region, From 2018-2023 ( USD Billion )
  2. North America Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  3. North America Livestock vaccines Market By Region, From 2018-2023 ( USD Billion )
  4. North America Companion vaccines Market By Region, From 2018-2023 ( USD Billion )
  5. North America Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  6. North America Live attenuated vaccines Market By Region, From 2018-2023 ( USD Billion )
  7. North America Inactivated vaccines Market By Region, From 2018-2023 ( USD Billion )
  8. North America Recombinant vaccines Market By Region, From 2018-2023 ( USD Billion )
  9. North America Toxoid vaccines Market By Region, From 2018-2023 ( USD Billion )
  10. North America Subunit vaccines Market By Region, From 2018-2023 ( USD Billion )
  11. North America DNA vaccines Market By Region, From 2018-2023 ( USD Billion )
  12. North America Conjugate vaccines Market By Region, From 2018-2023 ( USD Billion )
  13. North America Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  14. North America Bovine Market By Region, From 2018-2023 ( USD Billion )
  15. North America porcine Market By Region, From 2018-2023 ( USD Billion )
  16. North America Ovine Market By Region, From 2018-2023 ( USD Billion )
  17. North America Poultry Market By Region, From 2018-2023 ( USD Billion )
  18. North America Equine Market By Region, From 2018-2023 ( USD Billion )
  19. North America Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
  20. North America canine Market By Region, From 2018-2023 ( USD Billion )
  21. North America feline Market By Region, From 2018-2023 ( USD Billion )
  22. United States Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  23. United States Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  24. Canada Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
  25. Canada Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
  26. United States Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  27. Canada Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
  28. United States Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
  29. Canada Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )


$ 1234 3335